Diagnosing cancer, pregnancy complications

August 16, 2012
Diagnosing cancer or pregnancy complications
© Thinkstock

Based on their previous discovery of progesterone-induced blocking factor (PIBF), European scientists have developed a diagnostic assay that could be used to detect pregnancy complications or cancer.

PIBF is a required for maintaining a normal pregnancy. PIBF levels in the urine and blood of healthy pregnant women increase during pregnancy and decrease rapidly during delivery.

Previous work had shown that PIBF levels in women with were significantly lower, and demonstrated that PIBF blocks the autoimmune response which normally leads to the killing of rapidly growing fetal tissue.

Surprisingly, high levels of PIBF have been detected in , suggesting that it constitutes an essential marker for their discovery. The EU-funded PIBF proposal planned to develop a novel testing assay to diagnose malignant tumours, monitor tumour therapy and diagnose premature abortion risk.

Project scientists developed and validated an enzyme-linked immuno sorbent assay (ELISA) for measuring PIBF protein in biological fluids. Although the assay presented with limited sensitivity and precision due to the of the tested protein, it exhibited great reproducibility, making it ideal for inter-laboratory testing.

GMP grade reagents were also produced for the application of the assay in a clinical setting. Studies on clinical samples confirmed the potential role of PIBF in certain pathological pregnancies, and the elevated expression of PIBF in certain cancer patients.

However, similarly to other marketed tumour marker tests, the PIBF ELISA alone did not provide sufficient specificity and sensitivity to be used as a single screening . The developers of this kit are nonetheless hopeful that in combination with other diagnostic tests, this assay will contribute to the higher diagnostic standards of pathological pregnancies and malignant tumours.

Explore further: New prostate cancer test more specific, sensitive than PSA test

Related Stories

New prostate cancer test more specific, sensitive than PSA test

May 16, 2011
A new test for prostate cancer that measures levels of prostate specific antigen (PSA) as well as six specific antibodies found in the blood of men with the disease was more sensitive and more specific than the conventional ...

Study shows that new DNA test to identify Down syndrome in pregnancy is ready for clinical use

October 17, 2011
A new DNA-based prenatal blood test that can strikingly reduce the number of risky diagnostic procedures needed to identify a pregnancy with Down syndrome is ready to be introduced into clinical practice. The test can be ...

Current trend is to preserve pregnancy in patients diagnosed with cervical or ovarian cancer

February 9, 2012
The first paper in The Lancet Series on cancer in pregnancy explores the issues around gynaecological cancers, with cervical and ovarian being the most common. The current trend is to preserve pregnancy wherever possible. ...

Recommended for you

How rogue immune cells cross the blood-brain barrier to cause multiple sclerosis

November 21, 2017
Drug designers working on therapeutics against multiple sclerosis should focus on blocking two distinct ways rogue immune cells attack healthy neurons, according to a new study in the journal Cell Reports.

New simple test could help cystic fibrosis patients find best treatment

November 21, 2017
Several cutting-edge treatments have become available in recent years to correct the debilitating chronic lung congestion associated with cystic fibrosis. While the new drugs are life-changing for some patients, they do not ...

Researchers discover key signaling protein for muscle growth

November 20, 2017
Researchers at the University of Louisville have discovered the importance of a well-known protein, myeloid differentiation primary response gene 88 (MyD88), in the development and regeneration of muscles. Ashok Kumar, Ph.D., ...

New breast cell types discovered by multidisciplinary research team

November 20, 2017
A joint effort by breast cancer researchers and bioinformaticians has provided new insights into the molecular changes that drive breast development.

Brain cell advance brings hope for Creutzfeldt-Jakob disease

November 20, 2017
Scientists have developed a new system to study Creutzfeldt-Jakob disease in the laboratory, paving the way for research to find treatments for the fatal brain disorder.

Hibernating ground squirrels provide clues to new stroke treatments

November 17, 2017
In the fight against brain damage caused by stroke, researchers have turned to an unlikely source of inspiration: hibernating ground squirrels.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.